Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amelie S. Lotz-Havla

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Orphanet Journal of Rare Diseases

English

Related publications

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine

2017

English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics

Pharmacology

2016

English

Single-Dose Pharmacokinetics of Co-Crystal of Tramadol-Celecoxib: Results of a 4-Way Randomized Open-Label Phase I Clinical Trial in Healthy Subjects

British Journal of Clinical Pharmacology

Pharmacology

2017

English

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Asia-Pacific Journal of Clinical Oncology

Medicine

Oncology

2017

English

Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

Journal of the American Academy of Dermatology

Dermatology

2020

English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology

Oncology

2011

English

Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial

Stem cells translational medicine

Medicine

Developmental Biology

Cell Biology

2020

English

Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study

Alimentary Pharmacology and Therapeutics

English

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues

Endocrine Abstracts

2015

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Amelie S. Lotz-Havla

Efficacy, Safety and Population Pharmacokinetics of Sapropterin in PKU Patients <4 Years: Results From the SPARK Open-Label, Multicentre, Randomized Phase IIIb Trial

Related publications

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Single-Dose Pharmacokinetics of Co-Crystal of Tramadol-Celecoxib: Results of a 4-Way Randomized Open-Label Phase I Clinical Trial in Healthy Subjects

Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study

Pharmacokinetics and Safety of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: Results From a Phase 2 Open-Label Study

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Safety and Efficacy of Intrarenal Arterial Autologous CD34+ Cell Transfusion in Patients With Chronic Kidney Disease: A Randomized, Open-Label, Controlled Phase II Clinical Trial

Safety and Efficacy of Pasireotide in Dumping Syndrome-Results From a Phase 2, Multicentre Study

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues